These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3478159)

  • 21. Continuous ambulatory peritoneal dialysis and renal transplantation: a five year experience.
    Donnelly PK; Lennard TW; Proud G; Taylor RM; Henderson R; Fletcher K; Elliott W; Ward MK; Wilkinson R
    Br Med J (Clin Res Ed); 1985 Oct; 291(6501):1001-4. PubMed ID: 3931765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Rodger RS; Dewar JH; Turner SJ; Watson MJ; Ward MK
    Nephron; 1986; 43(3):169-72. PubMed ID: 3523268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of hemodialysis and continuous ambulatory peritoneal dialysis in children].
    Gagnadoux MF; Guest G
    Ann Pediatr (Paris); 1982 Nov; 29(9):627-9. PubMed ID: 7181408
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis.
    Johnson R; McNutt P; MacMahon S; Robson R
    Clin Chem; 1997 Nov; 43(11):2183-4. PubMed ID: 9365406
    [No Abstract]   [Full Text] [Related]  

  • 28. Myoglobin elimination in end stage kidney disease patients on renal replacement treatment.
    Stefanović V; Bogićević M; Mitić M
    Int J Artif Organs; 1993 Sep; 16(9):659-61. PubMed ID: 8294158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No need to measure serum aluminum in patients starting chronic ambulatory peritoneal dialysis.
    Musso CG; Bailey S; Shu M; Liakopoulos VC; Savaj S; Ghareeb S; Sahu K; Oreopoulos DG
    Perit Dial Int; 2002; 22(6):738. PubMed ID: 12556085
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

  • 31. [Continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Takác M
    Vnitr Lek; 1982 Jun; 28(6):602-8. PubMed ID: 7112984
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxidative metabolism of peripheral blood neutrophils in chronic renal failure on conservative and dialysis treatment.
    Luciak M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):93-5. PubMed ID: 1299177
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bilateral hydrothorax in a 13-year old girl treated with continuous ambulatory peritoneal dialysis renal replacement therapy].
    Bałasz I; Zurowska A; Kosiak W; Czarniak P; Zagozdzon I; Marczak E
    Pol Merkur Lekarski; 2001 Apr; 10(58):289-90. PubMed ID: 11434181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor markers in patients with chronic renal failure.
    Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
    Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. III. Treatment modalities for ESRD patients.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S51-62. PubMed ID: 10431002
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular risk factors in patients with chronic renal failure maintained on hemodialysis or continuous ambulatory peritoneal dialysis.
    Lippi G; Tessitore N; Gammaro L; Rugiu C; Maschio G; Guidi G
    Thromb Res; 2001 Mar; 101(6):517-9. PubMed ID: 11370638
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipid abnormalities in end stage renal disease.
    Oda H; Keane WF
    Nephrol Dial Transplant; 1998; 13 Suppl 1():45-9. PubMed ID: 9507498
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamins and continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Szabó T; Dandár V; Takác M
    Cas Lek Cesk; 1983 Aug; 122(34):1046-9. PubMed ID: 6627319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.